
AstraZeneca has “voluntarily paused” the clinical human trials after unexpected illness in volunteers.
COVID-19 Vaccine Update: In a rather unfortunate turn on the COVID-19 vaccine front, pharmaceutical major AstraZeneca has said that it “voluntarily paused” the clinical human trials of its vaccine candidate ‘Covishield’ with University of Oxford after one of the volunteers developed an unexpected illness.
“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow a review of safety data by an independent committee,” the pharma said in a statement.
According to the company, a volunteer developed an adverse reaction to the vaccine trial for reasons not yet known. However, they said that the participant is expected to recover.
Further explaining why it had to stop the trials immediately, AstraZeneca said it was a “routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the statement added.
Notably, the Oxford-AstraZeneca vaccine for coronavirus entered phase three clinical trials in the US last month, joining the group of vaccines in their final stage.
Meanwhile, the Serum Institute of India in Pune, which is handling the Phase 3 trials in India, is preparing a list of volunteers who will be inoculated free under the National Immunization Programme (NIP).
A total of 1,600 eligible participants of more than or equal to 18 years of age will be enrolled in the study, which will be conducted on 17 sites in India.
The remaining 1,200 participants from safety cohort will be randomly assigned in a 3:1 ratio to receive either Covishield or Placebo, respectively
About Post Author
The India Wire Team
Related
More Stories
IIT Guwahati and Parul University sign an MoU to advance the scope of healthcare through leading ayurvedic research
Emerging technologies have steadily gained mainstream acceptance within the research community and increasing availability of advanced tools is changing the...
Patient from Vadodara suffering from heart disease got new lease of life with donation from brain dead Rahul Solanki of Ahmedabad
Patient from Vadodara suffering from heart disease got new lease of life with donation from brain dead Rahul Solanki of...
Jayanti Dalmia inaugrates 19th chapter of Flo at Vadodara.
The FICCI Ladies Organisation (FLO) 19th Chapter “FLO Vadodara” was launched on Saturday, by Jayanti Dalmia, the 39th President of...
Vadodara based female entrepreneur launches India’s first eco friendly products e commerce portal zeroite.com
ZEROITE-THE ECO SPACE IS GUJARAT’S FIRST ZERO WASTE operational in Vadodara, city of Gujarat for last 2 years.Zeroite on the...
IndiGo ranked 6th largest carrier in the world by passenger volume in OAG Frequency & Capacity Statistics for March 2022
India’s leading carrier - IndiGo has been ranked the 6th largest airline by passenger volume in the OAG Frequency & Capacity...
Covishield &Covaxin prices slashed to Rs.225 from Rs.1200 and Rs.600
Vaccine makers Serum Institute of India and Bharat Biotech have reduced the price of coronavirus vaccines Covishield and Covaxin to...
Average Rating